Cerus Corporation (CERS)
NASDAQ: CERS · IEX Real-Time Price · USD
2.200
-0.010 (-0.45%)
At close: Jul 19, 2024, 4:00 PM
2.150
-0.050 (-2.27%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

Cerus Revenue

Cerus had revenue of $191.72M in the twelve months ending March 31, 2024, with 4.32% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $43.40M with 12.78% year-over-year growth. In the year 2023, Cerus had annual revenue of $186.80M.

Revenue (ttm)
$191.72M
Revenue Growth
+4.32%
P/S Ratio
2.12
Revenue / Employee
$300,967
Employees
637
Market Cap
406.76M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023186.80M-1.52M-0.81%
Dec 31, 2022188.32M28.80M18.05%
Dec 31, 2021159.52M45.27M39.62%
Dec 31, 2020114.25M20.48M21.83%
Dec 31, 201993.77M17.72M23.30%
Dec 31, 201876.05M24.73M48.17%
Dec 31, 201751.33M12.05M30.68%
Dec 31, 201639.28M5.05M14.76%
Dec 31, 201534.22M-2.19M-6.02%
Dec 31, 201436.42M-3.24M-8.17%
Dec 31, 201339.66M2.96M8.07%
Dec 31, 201236.70M6.09M19.91%
Dec 31, 201130.60M8.93M41.17%
Dec 31, 201021.68M3.70M20.55%
Dec 31, 200917.98M1.48M8.94%
Dec 31, 200816.51M5.46M49.47%
Dec 31, 200711.04M-19.27M-63.56%
Dec 31, 200630.31M16.81M124.57%
Dec 31, 200513.50M-414.00K-2.98%
Dec 31, 200413.91M4.25M43.93%
Dec 31, 20039.67M1.18M13.84%
Dec 31, 20028.49M3.96M87.21%
Dec 31, 20014.54M2.68M145.00%
Dec 31, 20001.85M-557.00K-23.13%
Dec 31, 19992.41M-495.30K-17.06%
Dec 31, 19982.90M-3.95M-57.62%
Dec 31, 19976.85M3.24M89.80%
Dec 31, 19963.61M-3.19M-46.91%
Dec 31, 19956.80M2.00M41.75%
Dec 31, 19944.80M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonida Senior Living 260.69M
Esperion Therapeutics 229.74M
Anika Therapeutics 169.26M
AxoGen 163.73M
Editas Medicine 69.41M
C4 Therapeutics 20.04M
Precigen 5.44M
Lyell Immunopharma 68.00K
Revenue Rankings